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Abstract
Background: Neural tube defects are among the most common birth defects, contributing to miscarriage, infant
mortality, severe congenital abnormalities and serious disabilities. It is burdensome to patients, caregivers,
healthcare systems and society. It could be reduced if women consume a folic acid supplement before and during
the early weeks of pregnancy. This study assesses folic acid usage and associated factors for the prevention of
neural tube defects among pregnant women in Ethiopia.
Methods: Institution based cross-sectional study was conducted on 417 systematically sampled, consented pregnant
women that visited Adama hospital medical college for antenatal care during August to November 2014. Pretested
interviewer administered questionnaire was used to collect socio-demographic, obstetric characteristics and folic acid
usage of women.
Result: About 48.4% of women took a folic acid supplement at different period of pregnancy; but, only 1.92% of
women took the supplement at a protective period against neural tube defects. Age, the early timing of antenatal
registration, was a preconception consulted, previous unsuccessful pregnancies and level of folic acid awareness were
significantly associated with folic acid usage for prevention of neural tube defects.
Conclusions: Folic acid usage during the protective period against neural tube defects among women in Ethiopia is
very low, so healthcare plan to improve intake of folic acid is required.
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Background
Neural tube defects (NTDs) are congenital anomalies
that result from failure of the neural tube to close be-
tween day 21 to 28 post conception [1–4]. NTDs are
contributing to miscarriage, infant mortality, severe con-
genital abnormalities and serious disabilities and are the
second most common congenital anomaly [3, 5]. NTDs
account for 10% of all neonatal mortality, 10% of the
burden of all congenital conditions and these defects are
responsible annually for 41,000 deaths and 2.3 million
disability-adjusted life years [3, 6]. NTDs are affecting
0.5–2 per 1000 pregnancies and occurring in about 2–
3% live births worldwide [1, 7, 8]. Because of the lower
living standard and low antenatal diagnosis and termin-
ation of pregnancy [9]; the incidence of NTDs in devel-
oping countries have been reported to be up to fourfold
higher than in developed ones [10]. The lifelong medical
and socioeconomic consequences of NTDs in affected
children are equally known to be worse in low-resource
settings [3]. A study conducted in Ethiopia reported that
hydrocephalus (35.5%) and neural tube defects (27.5%)
were the major leading causes of admission to hospitals
for surgical procedures among children [11].
Neural tube defects have a heterogeneous and multifac-
torial etiology, including genetic and environmental fac-
tors as well as predisposing maternal factors [3, 8, 12].
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Among known environmental factors folic acid deficiency
is the most common one [12–14].
The basic characteristic of embryonic and fetal develop-
ment is widespread cell division; and folic acid has a major
role in DNA and RNA synthesis, for cellular development
and division, the metabolism of amino acids and the regula-
tion of homocysteine in the blood [15–18]. Folic acid defi-
ciency is a serious problem that affects women worldwide
[4]. In Ethiopia, one in every three women had a deficiency
of folic acid, suggesting that these women are at a higher
risk of giving birth to a baby with NTDs [19].
Folic acid intake is limited by cooking losses and poor
bioavailability estimated to be from 50% to 82% [2, 19–22].
In addition, during pregnancy, maternal serum and erythro-
cyte concentrations of folic acid decline for several reasons:
increased demand, dilution secondary to increased intravas-
cular volume, increased folate catabolism and clearance, de-
creased absorption and inadequate intake [1, 6].
Many studies have documented that daily intake of 400
micrograms folic acid at least one month before preg-
nancy and the entire first trimester of pregnancy could re-
duce the risk of NTDs by up to 80% [4, 21, 23–25].
Because the neural tube closes by the fourth week after
conception, it is important that folic acid be consumed on
a regular basis before pregnancy [17, 26, 27].
Previous studies internationally shows different level of
folic acid usage for prevention of NTDs [1, 21, 23, 25, 28–
33] and discovered age [1, 21, 25, 28–30, 34], parity levels
[21, 25, 29, 30], smoking status [25], history of spontaneous
abortions [25], planning of pregnancy [21, 23, 28], number
of ANC visits [29, 30, 35], timing of ante-natal registration
[30], educational status [1, 21, 25, 30, 35], marital status
[21, 25, 35], monthly income [21, 25] and number of preg-
nancy [28] as factors associated with preconception folic
acid usage.
Although folic acid usage for prevention of NTDs
were well studied internationally, there are no published
reports that indicate the usage of folic acid at the recom-
mended time among pregnant women in Ethiopia. The
aim of this study was to assess folic acid usage and asso-
ciated factors for the prevention of NTDs among preg-
nant women in Ethiopia.
Methods
Study settings and period
In Ethiopia pregnant women obtain antenatal care
(ANC) in all government health facilities free of charge
starting from one month. ANC covers a wide range of
services including folic acid and iron supplement. But
there is no preconception care. Based on Ethiopian mini
Demographic and Health Survey 2011, 76% of urban
pregnant women received ANC from a skilled provider,
that is, from a doctor, nurse, or midwife. The study was
conducted from August to November 2014 in Adama
also known as Nazareth. Adama is a city located 99 km
southeast of Addis Ababa and was a previous capital of
the Oromia region from August to November 2014.
Study design and population
An institution based cross-sectional study was con-
ducted on pregnant women who visited Adama hospital
medical college, the former Haile Mariam Mamo me-
morial hospital, for the ANC. Women in 2nd and 3rd
trimester of pregnancy were included in the study.
Women who come repeatedly during the data collection
time were excluded.
Sample size determination and sampling procedure
The sample size was determined using a formula for a
single population proportion and calculated by Open Epi
Info version 3.5.3 statistical software package based on
the following assumptions: the target population greater
than 10, 000, since the proportion of folic acid usage for
NTD prevention in Ethiopia was unknown 50% was
used, significant level at 95% confidence interval and
margin of tolerable sampling error 5%. After calculating
sample size was 383. After adding 10% for non-response
the final sample size becomes 422. The study partici-
pants were selected by using a systematic random sam-
pling method. After taking informed consent, the
participants were interviewed in the waiting room before
entering to ANC unit.
Data collection tools and study variables
A pretested interviewer administered questionnaire writ-
ten in English was prepared. The questionnaire was
translated into the local language (Amharic) to the
guardians then translated back to English to evaluate its
consistency. A detailed history of socio demographic
characteristics (age, marital status, educational status,
monthly income which was scaled as birr per month, oc-
cupation, husband educational status; obstetric charac-
teristics (number of pregnancies, preconception consult
which means asking advise from healthcare provider by
own initiation, number of antenatal visit, planning of
pregnancy, history of unsuccessful pregnancy, previous
history of a baby with NTDs) and awareness and use of
folic acid were assessed by interviewing the women. The
dependent variable was folic acid usage for NTD preven-
tion. The independent variables were socio demographic
characteristics, obstetric characteristics and level of in-
formation about folic acid. Figure 1 shows the concep-
tual framework for folic acid usage and associated
factors. Folic acid user for NTD prevention was defined
in this study as a woman who took folic acid at least one
month before pregnancy and continue for three months
after pregnancy. Total user of folic acid were women
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who took folic acid at any time during current preg-
nancy for at least one month.
Data processing and analysis
Data were entered into Epi-Info version 3.5.3 and exported
to SPSS version 20 statistical software for analysis. Descrip-
tive statistics were carried out using percentage and pre-
sented in tables. Bivariate logistic regression analysis, Chi
square and Fisher’s exact test were conducted to assess the
association between dependent and independent variables.
Odds ratio with 95% confidence interval and p-value were
used to evaluate the association between the dependent
and independent variables. A p-value less than 0.05 was
considered as statistically significant.
Ethical considerations
The study was conducted following ethical approval by
the University of Gondar, College of Medicine and
Health Sciences, School of Medicine Ethical Committee.
Permission was taken from the hospital administrators.
Informed consent was taken from the study participants.
Participation in the study was voluntary and refusal was
possible. The study did not involve any harmful proced-
ure. To keep confidentiality codes were used and an
unauthorized person did not have access to the data.
Results
A total of 422 pregnant women attending ANC in
Adama hospital medical college from August to Novem-
ber 2014 were approached to fill a questioner but 417
women willing to fill it. The response rate was 98.8%.
The mean respondent age was 25.3 years, 45.3% of the
respondents were aged less than 25 years, 49.4% of the
women were aged between 25 and 35 years, and 5.3%
were aged 35 and above. The minimum age was 16 and
the maximum was 41. Household monthly income was
less than 2500ETB in 57.3% of the respondents and
greater than or equal to 2500 to 42.7% of the respon-
dents. Table 1 shows the detail socio demographic char-
acteristics of the women.
About 46.3% the women were primigravidae while
49.2% had 2–4 pregnancies and 4.6% had 5 or more
pregnancies. The number of pregnancies ranges from 1
to 10 (2 ± 1.3). The mean gestational age at the time of
interview was 29.2 weeks with the minimum 13 week
and maximum 40. About 11.3% of the women consulted
a healthcare provider when they plan to become preg-
nant. Among those who consulted healthcare providers
93.6% could mention what was done by a healthcare
provider when they consult them. Advice was reported
by 4.5%, general check up by 72.7% and general checkup
plus folic acid supplement by 18.2%.
Of al1 9.7% of women comes for the first visit while
63.3% comes for the 2nd to 4th visit and 17.0% comes
for 5th and more visits at the time of interview. The
month of first ANC visit ranges from one month to nine
months (mean = 3.8, median = 4, mode = 4). 42.2% of
the women made their first ANC visit in the first trimes-
ter, 53.5% in the second trimester and 4.3% in the third
trimester of pregnancy. 19.4% had a history of unsuc-
cessful pregnancy in a lifetime and 1.7% of the women
had a history of a baby with other birth defects.
The current pregnancy was planned by 71% of the
women. Among women who planned pregnancy 48%
stopped using contraceptive without consulting health-
care provider, 21% consulted care giver before stopping
Obstetric factors  
Number of pregnancies, 
history unsuccessful 
pregnancy, previous 
history of a baby with 
NTD, preconception 
consult  
Baseline socio-
demographic factors  
Age, marital status, 
monthly income, 
occupation, paternal 
educational status  
Awareness factors  
Number of antenatal visit, 
planning of pregnancy, 
educational status, level 
of folic acid awareness  
Folic acid 
usage for 
NTD 
preventio
n 
Fig. 1 Conceptual framework to assess folic acid usage and associated factors for prevention of NTDs among pregnant women developed
from literatures
Dessie et al. BMC Pregnancy and Childbirth  (2017) 17:313 Page 3 of 8
birth control and 31.1% did not use birth control. Table 2
shows the detail obstetric history of the women.
Folic acid was prescribed for 54.9% of the women for
the current pregnancy. Of those women, 77.3% took folic
acid daily, 10.9% forgot 1–2 times per week, 6.6% inter-
rupted, and 5.2% never took the supplement. Among 217
women who took folic acid during current pregnancy
6.9% used less than one month, 182 (83.9%) used for one
to three months, 15 (6.9%) used for four to six months
and 5 (2.3%) for seven months and above. Among the pre-
scribed women, 3.5% started to take folic acid supple-
ments before pregnancy and 11.6% started in the first
trimester. The remaining 51.1% and 33% of the women
started taking the supplement at their second and third
trimester of pregnancy respectively. The overall users of
folic acid supplement become 48.4% (202/417). But only 8
of the users took folic acid at a protective period against
NTD. This makes the total user of folic acid supplement
for NTD prevention 1.92% (Table 3).
Folic acid usage for NTD prevention was significantly
associated with advanced age (p value =0.02 and OR = 9.4
with 95% CI 1.14–76.8), early antenatal registration (p
value =0.03 and OR = 0.974 with 95% CI 0.96–0.99),
number of ANC visit (p value = 0.04), consultation dur-
ing preconception period (p value = 0.000 and OR = 0.063
with 95% CI 0.15 to 0.275), previous history of unsuc-
cessful pregnancies (p value = 0.04 and OR = 4.3 with
95% CI 1.1 to 17) and level of folic acid awareness (p
value = 0.00).
There was no significant correlation between folic acid
usage and the women’s educational status, occupation,
monthly household income, number of pregnancy and
partner’s educational status.
The variables planning of pregnancy, having a his-
tory of a baby with a birth defects and experiencing
illness during current pregnancy did not reach a sig-
nificant level. But all of these had correlation with
folic acid usage for NTD prevention. Table 4 shows
the detail of folic acid usage and associated factors
for NTDs prevention.
Table 1 Socio demographic characteristic of women attending
ANC in Adama Hospital Medical College 2014 N = 417
Variables Frequency Percent
Age <25 years 189 45.3
25–34 years 206 49.4
= > 35 years 22 5.3
Marital status Not married 20 4.8
Married 337 95.2
Educational status Illiterate 38 9.1
Primary education 156 37.4
Secondary education 146 35.0
College diploma and
degrees
77 18.5
Monthly income <2500 ETB 239 57.3
>2500 ETB 178 42.7
Occupation Housewife 242 58
Working women 175 42
Paternal educational
status
Illiterate 26 6.2
Primary education 110 26.4
Secondary education 151 36.2
College diploma, degree 130 31.2
Table 2 Obstetric history of women attending ANC in Adama
hospital medical college 2014 N = 417
Variable Frequency(n) Percent
Number of pregnancy Primigravida 193 46.3
2–4 205 49.2
> = 5 19 4.6
Preconception consult Yes 47 11.3
No 370 88.3
What has been done
during consultation
(N = 44)
Advice 2 4.5
General check up 32 72.7
General checkup & folic
acid supplement
8 18
Remove birth control 2 4.5
Month of first ANC Visit First trimester 176 42.2
Second trimester 223 53.5
Third trimester 18 4.3
Number of ANC visit first visit 82 19.7
2nd -4th 264 63.3
More than 4th 71 17.0
History of unsuccessful
pregnancy in life time
No 345 80.6
Yes 81 19.4
Type of unsuccessful
pregnancy in life time
Spontaneous abortion 63 15.1
NTD 3 0.7
Other(still birth, congenital
anomaly)
15 3.6
History of a baby with birth
defect
No 410 98.3
Yes 7 1.7
Diagnosed Diabetes
mellitus
No 409 98.08
Yes 8 1.92
Planning of pregnancy Yes 296 71
No 121 29
Action when plans to
become pregnant
(N = 296)
I stopped without
consulting healthcare
provider
142 48
I consulted healthcare
provider before stopping
BC
62 21
I did not use birth control 92 31.1
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Discussions
Intake of folic acid at least one month before pregnancy
and the entire first trimester is highly recommended to
decrease birth defects, particularly NTDs [10, 17, 36].
But, the prevalence of folic acid usage at the recom-
mended time in Adama, Ethiopia was found to be 1.92%.
Ethiopia is one of the developing countries where the in-
cidence of NTDs is highly prevalent and where 1/3 of
women were affected by folate deficiency [10, 19].
In the present study, pregnancy was planned by 71%
of the interviewed women, which was consistent with
the planning of pregnancy in Croatia [21]. It was higher
than usual reports of 50% of pregnancies, being un-
planned [7, 16, 34].
Of those women who planned pregnancy 69% used
contraceptive and 30.4% inform the healthcare provider
before ceasing the contraceptive. As compared to survey
in Europe, where 18% of the women were consulted
healthcare provider prior to stopping contraceptive, the
finding in this study was higher [24]. About 11.3% of the
women consulted healthcare providers, particularly about
their pregnancy when they plan to become pregnant.
Despite all these convenient conditions to give a folic acid
supplement only 2.7% of the planning women were pre-
scribed for folic acid during the protective period against
NTD, which was very low as compared with 21% usage in
Croatia that had similar levels of planned pregnancy [21].
Even though the number of women who consulted
healthcare providers prior to stopping contraceptive in
the present study was higher than surveyed women in
Europe, usage in Ethiopian women was extremely low as
compared to usage by 28% plan to become pregnant and
55% pregnant women in Europe [24].
In this study, 1.92% of the women were diabetic, 0.7%
women had previous history of NTD pregnancies, both
of which are high risk factors for occurrence and recur-
rence of NTD [3]. However, none of them were user of
folic acid at the recommended time. This finding was in
contrast to the study done in Nigeria, where 40% of
women with a previous history of NTD pregnancy were
the user at protective period [1].This difference may be
because of the difference in health policy, i.e. there is
preconception care in Nigeria but not in Ethiopia [37].
The occurrence of NTDs among spontaneously aborted
fetuses is 10-fold higher than the rate of NTDs at birth
[17]. In this study, 15.1% of the study subject had at least
one spontaneous abortion in their lifetime. So those women
are at high risk for having a baby affected by NTDs.
Women whose age were above 25 were 9.4 fold user
of folic acid at protective period than women age 25 and
below which was consistent with other studies in USA
[27, 34], Croatia [21], Lebanon [25], and Tanzania [29].
This finding was in contrast to the other study in Leba-
nese where young women were more user [28].
Early timing of antenatal registration and number of
ANC visits also positively associated with folic acid
usage for NTD prevention as other studies done in
Tanzania, India, Honduras [29, 30, 35].The study find-
ings were consistent with other studies who have re-
ported that the level of folic acid awareness predicts folic
acid usage at protective period.
In this study, women who consulted healthcare pro-
viders when they plan to become pregnant were 6.3
times more likely to take folic acid at protective period
than who did not consult. Similar to studies in Lebanon
and Nigeria previous history of unsuccessful pregnancies
was positively associated with intake of folic acid at pro-
tective period against NTDs [1, 25].
Data reported during the last 7 years from USA,
Australia, Lebanon, Iran, United Arab Emirate and
Nigeria shows folic acid usage at protective period
against an NTDs range from 2.5% to 76% [1, 5, 10,
15, 25, 31, 36, 38]. The prevalence of folic acid users
in this study is even lower than the least range. How-
ever, it is higher than a study done among Honduran
women in 2007 which was 0.2% [10].
Table 3 Folic acid usage and associated factors for NTD
prevention among women attending ANC in Adama Hospital
Medical College 2014
Variable Category Frequency Percent
Prescribed for folic acid
supplement for current
pregnancy (N = 417)
Yes 229 54.9
No 188 45.1
Do you take as
recommended(N = 229)
yes I took as
recommended
177 77.3
sometimes I forgot 25 10.9
Interrupted 15 6.6
I never took FA 12 5.2
When do you start to take
folic acid (N = 229)
before I become
pregnant
8 3.5
first trimester 26 11.5
Second trimester 118 51.1
Third trimester 77 33.9
Total month of folic acid
intake(N = 217)
Less than 1 month 15 6.9
1–3 month 181 83.9
4–6 month 16 6.9
7 month and above 5 2.3
Level of folic acid awareness Uninformed 328 78.7
Somewhat
informed
39 9.4
Informed 50 12
Total user of folic acid Yes 202 48.7
No 214 51.3
Folic acid user for NTD
prevention
Yes 8 1.9
No 409 98.1
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In Ethiopia, there are health facilities distributed in
every city and villages in which healthcare providers de-
liver different medical and health need of the society in-
cluding the ANC. However, folic acid usage is very low.
The poor intake of folic acid among Ethiopian women
could be a result of low recommendation from policy
makers, less prescription, and recommendations by health-
care providers and lack of awareness about folic acid sup-
plements, its importance and the recommended time
among women. The other one may be failures of healthcare
providers to prescribe folic acid at protective time and lack
of preconception care.
The study is a hospital based study on women who
seek routine ANC. The result may only reflect usage
among women who might have high health service seek-
ing behavior. Another limitation of the study was it is
conducted in one region, relatively a big city. So the
finding of this study may not be generalized to other re-
gions of the country, especially rural areas and small
towns. Despite those limitations, the present study pro-
vides some insight into the practice of women for usage
of folic acid for prevention of neural tube defects.
Conclusions
Even though preconception folic acid intake is simple mea-
sures to prevent many severe birth defects, particularly
NTDs; in Ethiopia it is unnoticed by policy makers, less
prescribed at the protective period by healthcare providers,
underused by pregnant women and/or women planning
pregnancy.
The folic acid intake rate for NTD prevention in the
present study indicates special intervention plans should
be developed by health policy makers. This intervention
could be screening childbearing-age women for folic acid
use and providing information on the benefits of folic acid
supplementation, as well as training healthcare providers
on NTD and other birth defect prevention mechanisms,
providing education for the whole community even early
in high school level using media and other methods.
The other most important intervention that could be done
by policy makers and other stakeholders is starting precon-
ception care for women who plan to become pregnant. This
action might improve folic acid usage for preventing NTDs
and other birth defect and also early ANC registration.
Folic acid rate of intake in this study also indicates urgent
action is required from healthcare providers to improve
usage at protective period against NTDs and other congeni-
tal anomalies. So further effort is required and it is
necessary to have health education on NTDs and folic acid
usage during premarital health examination, when
providing family planning services and during other contact
with the community.
Table 4 Statical Analysis of Folic Acid Usage and Its Dependent Variables
Covariates Folic acid user OR(95% CI) P-value
No Yes
Number of pregnancy Primigravida 190(98.4%) 3(1.6%) 1.45(0.341–6.13) 0.426
Other 219(97.8%) 5 (2.2%)
Preconception consult Yes 39(83%) 8(17%) 0.83(0.729–0.944) 0.000
No 370(100%) 0(0.0%)
Have ANC visit for current pregnancy Yes 327(97.6%) 8(2.4%) 0.98(0.96–0.993) 0.171
No it is first 82(100%) 0(0.0%)
Month of first visit of ANC First trimester 305(97.4%) 8(2.6%)) 0.97(0.96–0.99) 0.032
Other 103(100%) 0(0.0%)
Number of ANC visits 1st visit 82(100%) 0(0.0%) Not applicable .046
2nd to 4th visit 260(98.5%) 4(1.5%)
>4th visit 67(94.4%) 4(5.6%)
History of unsuccessful pregnancy in life time No 332(98.8%) 4(1.2%) 4.31(1.056–17.62) 0.04
Yes 77(95.1%) 4(4.9%)
History of a baby with birth defect No 403(98.3%) 7(1.7%) 9.6(1.016–17.62) 0.128
Yes 6(85.7%) 1(14.3%)
Planning of pregnancy Planned 288(97.3%) 8(2.7%) 0.97(0.95–0.992) 0.063
Unplanned 121 0(0.0%)
Level of folic acid awareness Uninformed 328(100%) 0(0.0%) Not applicable 0.000
Somewhat informed 39(100%) 0(0.0%)
Informed 42(84%) 8(16%)
Dessie et al. BMC Pregnancy and Childbirth  (2017) 17:313 Page 6 of 8
Abbreviations
ANC: Ante natal care; CI: Confidence interval; ETB: Ethiopian birr; NTD: Neural
tube defect
Acknowledgments
I sincerely appreciate Adama hospital medical college administration
and hospital staffs for their kind cooperation during the data
collection time. Also, I would like to extend my appreciation to the
University of Gondar, college of medicine and health science for
funding me.
Funding
This research has been funded by University of Gondar, Gondar, Ethiopia.
The university gives a grant in order to conduct the study but have no any
role in study design; collection, analysis, and interpretation of data; writing
the report; and the decision to submit the report for publication.
Availability of data and materials
The corresponding author can provide information described in the
manuscript, including all relevant raw data, to any scientist wishing to use
them for non-commercial purposes, without breaching participant
confidentiality.
Authors’ contributions
MA conceive the study, develop the proposal, collected data, analyze and
interpret data, wrote the draft of the manuscript. EG revise the draft of the
proposal, interpreted data and revise the manuscript. SB analyze and
interpret data, revise the draft of the manuscript along with MA. AW
supervised the collection of data, interpret data, revised the draft of the
manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study was conducted following ethical approval by the University of
Gondar, College of Medicine and Health Sciences, School of Medicine Ethical
Committee. Permission was taken from the hospital administrators. Informed
consent was taken from the study participants. Participation in the study was
voluntary and refusal was possible. The study did not involve any harmful
procedure. To keep confidentiality codes were used and unauthorized
person did not have access to the data.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Anatomy, School of Medicine, Collage of Medicine and
Health Sciences, University of Gondar, Gondar, Ethiopia. 2Department of
Biostatic and Epidemiology, Institute of public health, Collage of Medicine
and Health Sciences, University of Gondar, Gondar, Ethiopia. 3Department of
Biostatic and Epidemiology, school of public health, Wolaita Sodo University,
Wolaita Sodo, Ethiopia.
Received: 20 April 2017 Accepted: 11 September 2017
References
1. Anzaku AS. Assessing folic acid awareness and its usage for the prevention
of neural tube defects among pregnant women in Jos, Nigeria. J Basic Clin
Reprod Sci. 2013;2(1):13–7.
2. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr. 2007;85(suppl):
285S–8S.
3. Nelson AL. Folates for reduction of risk of neural tube defects: using oral
contraceptives as a source of Folate. Open Access J Contracept. 2011;2:137–50.
4. Burke B, Daniel KL, Latimer A, Mersereau P, Moran K, Mulinare J, et al.
Preventing neural tube birth defects. A Prevention Model and Resource
Guide [Internet]. 2009;2014:CS202063.
5. Nosrat SB, Sedehi M, Golalipour MJ. Knowledge and practice of urban
Iranian pregnant women towards folic acid intake for neural tube defect
prevention. J Pak Med Assoc. 2012;62(8):785–9.
6. Safi J, Joyeux L, Chalouhi GE. Periconceptional Folate Deficiency and
Implications in Neural Tube Defects. J Pregnancy 2012;2012. Article ID
295083. p. 9. https://www.hindawi.com/journals/ip/2012/295083/.
7. Rofail D, Colligs A, Abetz L, Lindemann M, Maguire L. Factors contributing
to the success of folic acid public health campaigns. J Public Health. 2011;
34(1):90–9.
8. Greene NDE, Stanier P, Copp AJ. Genetics of human neural tube defects.
Hum Mol Genet. 2009;18(2):113–29.
9. Uba AF, Isamade ES, Chirdan LB, Edino ST, Ogbe ME, Igun GO.
Epidemiology of neural tube defects in north Central Nigeria. Afr J Paediatr
Surg. 2004;1(1):16–9.
10. Lawal TA, Adeleye AO. Determinants of folic acid intake during
preconception and in early pregnancy by mothers in Ibadan, Nigeria. Pan
Afri Med J. 2014;19:113.
11. Tadesse L, Tafesse F, Hamamy H. Communities and community genetics in
Ethiopia. Pan Afr Med J. 2014;18:115.
12. Ashley-Koch A, Gregory S, Worley G, Enterline D, Cope H. Neural Tube
Defects (NTDs). Center for Human Disease Modeling. Duke University; 2012.
13. World Health Organization. Prevention of Neural Tube Defects. Department
of Making Pregnancy Safer. Switzerland: World Health Organization; 2006.
14. Milla GR, Flores AL, Umaña E, Mayes I, Rosenthal J. Postpartum women in
the Honduran health system: folic acid knowledge, attitudes, and practices.
Pan Am J Public Health. 2007;22(5):340–7.
15. Mashayekhi SO, Dilmaghanizadeh M, Sattari MR. A survey on the
consumption, knowledge and attitude of pregnant women toward the
effects of folic acid on pregnancy outcome in Tabriz. Iran J Child Neurol.
2011;5(1):35–42.
16. Cellebroersstraat. Fortify Grains to Prevent Neural Tube Defects in Africa
Advocacy Toolkit. Brussels: International Federation for Spina Bifida and
Hydrocephalus; 2010.
17. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy.
Am J Clin Nutr. 2000;71(suppl):1295S–303S.
18. De-Regil L, Fernández-Gaxiola A, Dowswell T, Peña-Rosas J. Effects and
Safety of Periconceptional Folate Supplementation for Preventing Birth
Defects. Cochrane Database Syst Rev. 2010;10(CD007950). doi:10.1002/
14651858.CD007950.pub2.
19. Haidar J, Melaku U, Pobocik R. Folate deficiency in women of reproductive
age in nine administrative regions of Ethiopia: emerging public health
problem. S Afr J Clin Nutr. 2010;23(3):132–7.
20. Deepti K, Anila H, Arup C, Vinohar B. Determinants of knowledge regarding
folic acid in Periconceptional use among pregnant mothers in southern
India. J Dent Med Sci (IOSR-JDMS). 2013;4(3):25–9.
21. Vitale K, Mujki A, Todorovi G, Tulchinsky TH. Is level of knowledge, attitude
and use of folic acid among pregnant women in Croatia a call for public
health action? Period Biol. 2009;111(3):329–35.
22. Pagan K, Jinrong H, Goldenberg R, Cliver S, Tamura T. Effect of smoking on
serum concentrations of Total Homocysteine and B vitamins in mid-
pregnancy. Clin Chim Acta. 2001;306:103–9.
23. Tekkesin N, Taser F. Folic acid usage and awareness in pregnant women in
Istanbul, Turkey. J Hosp Adm. 2012;1(1):9–14.
24. Bitzer J, Von Stenglin A, Bannemerschult R. Women’s Awareness and
Periconceptional use of folic acid: data from a large European survey. Int J
Women’s Health. 2013;5:201–13.
25. Tamim H, Harrison G, Atoui M, Mumtaz G, El-Kak F, Seoud M, et al.
Preconceptional folic acid supplement use in Lebanon. Public Health
Nutr. 2008;10:1–6.
26. Meyer RE, Hayes AG, Morgan AJ, Devine JE, Powers KE. Knowledge and Use
of Folic Acid among North Carolina Women. State Cent Health Stat. 2001;
126(Folic Acid Use).
27. Cleves MA, Hobbs CA, Collins HB, Andrews N, Smith LN, Robbins JM. Folic
acid use by women receiving routine gynecologic care. Obstet Gynecol.
2004;103(4):748.
28. Hage CN, Jallou M, Sabbah M, Adib SM. Awareness and intake of folic acid
for the prevention of neural tube defects among Lebanese women of
childbearing age. Matern Child Health J. 2012;16(1):258–65.
Dessie et al. BMC Pregnancy and Childbirth  (2017) 17:313 Page 7 of 8
29. Ogundipe O, Hoyo C, stbye T, Oneko O, Manongi R, Lie RT, et al. Factors
associated with prenatal folic acid and iron supplementation among 21,889
pregnant women in northern Tanzania. BMC Public Health. 2012;12:481.
30. Roy MP, Mohan U, Singh SK, Singh VK, Srivastava AK. Socio-economic
determinants of adherence to iron and folic acid tablets among rural ante-
Natal mothers in Lucknow, India. Natl J Community Med. 2013;4(3):386–91.
31. El-mani, Souad Faraj. Knowledge, Behavior and Practices of Pregnant
Women in Wollongong Regarding Folic Acid and Iodine Nutrition after the
Introduction of Mandatory Fortification Program, Master of Sceince -
Research Thesis, Faculty of Health and Behavioral Science. University of
Wollongong. 2013. http://ro.uow.edu.au/theses/4112.
32. Wu DY, Brat G, Milla G, Kima J. Knowledge and use of folic acid for
prevention of birth defects amongst Honduran women. Reprod Toxicol.
2007;2007(23):600–6.
33. Maina-Gathigi L, Omolo J, Wanzala P, Lindan C, Makokha A. Utilization of
folic acid and iron supplementation services by pregnant women attending
an antenatal Clinic at a Regional Referral Hospital in Kenya. Matern Child
Health J. 2013;17(7):1236–42.
34. Gallup. Improving preconception health: Women’s knowledge and use of
folic acid. USA: March of Dimes Foundation; 2008.
35. Popa AD, Niţă O, Graur LI, Popescu RM, Botnariu GE, Mihalach L. Nutritional
knowledge as a determinant of vitamin and mineral supplementation
during pregnancy. BMC Public Health. 2013;13:1105.
36. Canfield AM, Przybyla MS, Case AP, Ramadhani T, Suarez U, Dyer J. Folic
acid awareness and supplementation among Texas women of childbearing
age. Prev Med. 2006;43:27–30.
37. Ezegwui HU, Dim C, Dim N, Ikeme AC. Preconception care in south eastern
Nigeria. J Obstet Gynaecol. 2008;28:8.
38. Al-Hossani H, Abouzeid H, Salah MM, Farag HM, Fawzy E. Knowledge and
practices of pregnant women about folic acid in pregnancy in Abu Dhabi,
United Arab Emirates. East Mediterr Health J. 2010;16(4):402–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Dessie et al. BMC Pregnancy and Childbirth  (2017) 17:313 Page 8 of 8
